State Street Corporation has acquired a 4.8% stake in Biocryst Pharmaceuticals, signaling strong interest in the biological products sector.
| Name | BIOCRYST PHARMACEUTICALS INC |
|---|---|
| CIK | 0000882796 |
| Tickers | BCRX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 621413174 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 919-859-1302 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
State Street Corporation has acquired a 4.8% stake in Biocryst Pharmaceuticals, signaling strong interest in the biological products sector.
Biocryst Pharmaceuticals Inc. reports third-quarter results, showcasing advancements in its biological product pipeline and ongoing commitment to innovation.
BioCryst Pharmaceuticals announces robust Q3 2026 results, showcasing growth in revenue and profitability, while maintaining guidance for ORLADEYO.
1968 filing rows loaded from submissions recent; extra archives: CIK0000882796-submissions-001.json (968 filings, 1995-02-14 to 2016-03-12).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000275 | 005-44055 | 261562589 | 34 | 12915 | |||
| 2026-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000622 | 005-44055 | 261537825 | 34 | 8100 | |||
| 2026-11-04 | 10-Q | 10-Q | 0001628280-26-070112 | 000-23186 | 261522007 | 34 | 10170381 | 1 | 1 | |
| 2026-11-04 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-26-007097 | 000-23186 | 261519995 | 34 | 451335 | 1 | 1 |
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000065 | 6093 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000063 | 4670 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000061 | 4629 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000059 | 4613 | ||||||
| 2026-09-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000057 | 4609 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000919 | 005-44055 | 261282925 | 34 | 14657 | |||
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000420 | 005-44055 | 261251593 | 34 | 8125 | |||
| 2026-08-05 | S-8 | FORM S-8 | 0001171843-26-005245 | 333-298006 | 261243897 | 33 | 203873 | 1 | 1 | |
| 2026-08-05 | 10-Q | 10-Q | 0001628280-26-053300 | 000-23186 | 261243323 | 34 | 9649360 | 1 | 1 | |
| 2026-08-05 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-26-005223 | 000-23186 | 261241276 | 34 | 387483 | 1 | 1 |
| 2026-08-04 | 8-K/A | FORM 8-K/A | 2.05 | 0001171843-26-005168 | 000-23186 | 261235393 | 34 | 192417 | 1 | 1 |
| 2026-06-29 | 8-K | FORM 8-K | 2.05,7.01,9.01 | 0001171843-26-004333 | 000-23186 | 261131290 | 34 | 240673 | 1 | 1 |
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000055 | 7113 | ||||||
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000053 | 8057 | ||||||
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000052 | 7070 | ||||||
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000045 | 7052 | ||||||
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000043 | 7078 | ||||||
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000041 | 7074 | ||||||
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000039 | 8538 | ||||||
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000037 | 7058 | ||||||
| 2026-06-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000035 | 7073 | ||||||
| 2026-06-12 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-26-004096 | 000-23186 | 261086737 | 34 | 372967 | 1 | 1 |
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000033 | 4670 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000031 | 6093 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000029 | 4613 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000027 | 4628 | ||||||
| 2026-06-02 | 4 | PRIMARY DOCUMENT | 0000882796-26-000025 | 4609 | ||||||
| 2026-05-19 | 4 | PRIMARY DOCUMENT | 0000882796-26-000023 | 4846 | ||||||
| 2026-05-18 | 144 | xsl144X01/primary_doc.xml | 0001628280-26-036012 | 000-23186 | 26994328 | 33 | 5187 | |||
| 2026-05-15 | 4 | PRIMARY DOCUMENT | 0000882796-26-000021 | 8649 | ||||||
| 2026-05-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003553 | 000-23186 | 26972286 | 33 | 5052 | |||
| 2026-05-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000211 | 005-44055 | 26966348 | 34 | 8128 | |||
| 2026-05-06 | 10-Q | 10-Q | 0001628280-26-031238 | 000-23186 | 26948324 | 34 | 8765411 | 1 | 1 | |
| 2026-05-06 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-26-003052 | 000-23186 | 26945785 | 34 | 323987 | 1 | 1 |
| 2026-05-04 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-26-002960 | 000-23186 | 26934590 | 34 | 227285 | 1 | 1 |
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000218 | 005-44055 | 26917679 | 34 | 7439 | |||
| 2026-04-23 | ARS | ARS | 0001140361-26-016385 | 000-23186 | 26888920 | 34 | 3305088 | |||
| 2026-04-23 | DEFA14A | DEFA14A | 0001140361-26-016373 | 000-23186 | 26888752 | 34 | 263359 | |||
| 2026-04-23 | DEF 14A | DEF 14A | 0001628280-26-026822 | 000-23186 | 26888488 | 34 | 3647089 | 1 | 1 | |
| 2026-04-07 | 4 | PRIMARY DOCUMENT | 0000882796-26-000019 | 7246 | ||||||
| 2026-04-07 | 3 | xslF345X06/ownership.xml | 0001171843-26-002301 | 11915 | ||||||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000742 | 005-44055 | 26798249 | 34 | 7199 | |||
| 2026-03-24 | 4 | PRIMARY DOCUMENT | 0000882796-26-000017 | 8402 | ||||||
| 2026-03-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-002529 | 000-23186 | 26777073 | 33 | 4339 | |||
| 2026-03-18 | 4 | PRIMARY DOCUMENT | 0000882796-26-000015 | 9017 | ||||||
| 2026-03-16 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-002383 | 000-23186 | 26756935 | 33 | 5059 | |||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000882796-26-000013 | 4539 | ||||||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000882796-26-000011 | 12013 | ||||||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000882796-26-000009 | 4592 | ||||||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000882796-26-000007 | 4471 | ||||||
| 2026-03-03 | 4 | PRIMARY DOCUMENT | 0000882796-26-000005 | 4475 | ||||||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-001679 | 000-23186 | 26706951 | 33 | 4448 | |||
| 2026-02-26 | 10-K | 10-K | 0001628280-26-012240 | 000-23186 | 26687703 | 34 | 15253619 | 1 | 1 | |
| 2026-02-26 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-26-001119 | 000-23186 | 26681698 | 34 | 435482 | 1 | 1 |
| 2026-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193805-26-000127 | 005-44055 | 26625380 | 34 | 16760 | |||
| 2026-02-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-26-000024 | 005-44055 | 26609492 | 34 | 8021 | |||
| 2026-01-27 | 4 | PRIMARY DOCUMENT | 0000882796-26-000003 | 9390 | ||||||
| 2026-01-27 | 3 | xslF345X02/ownership.xml | 0001171843-26-000446 | 11507 | ||||||
| 2026-01-23 | 8-K/A | FORM 8-K/A | 5.02 | 0001171843-26-000405 | 000-23186 | 26556934 | 34 | 189428 | 1 | 1 |
| 2026-01-23 | 8-K | 8-K | 1.01,2.01,2.03,7.01,9.01 | 0001140361-26-002200 | 000-23186 | 26556882 | 34 | 2120896 | 1 | 1 |
| 2026-01-12 | 8-K | FORM 8-K | 2.02,7.01,8.01,9.01 | 0001171843-26-000213 | 000-23186 | 26527038 | 34 | 246123 | 1 | 1 |
| 2026-01-09 | 3 | xslF345X02/ownership.xml | 0001171843-26-000173 | 20584 | ||||||
| 2026-01-09 | 8-K | FORM 8-K | 7.01 | 0001171843-26-000154 | 000-23186 | 26521336 | 34 | 185404 | 1 | 1 |
| 2025-12-23 | 4 | PRIMARY DOCUMENT | 0000882796-25-000045 | 6169 | ||||||
| 2025-12-23 | 4 | PRIMARY DOCUMENT | 0000882796-25-000043 | 6409 | ||||||
| 2025-12-23 | 4 | PRIMARY DOCUMENT | 0000882796-25-000041 | 15484 | ||||||
| 2025-12-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007875 | 000-23186 | 251591469 | 33 | 6940 | |||
| 2025-12-19 | 4 | xslF345X05/ownership.xml | 0001171843-25-008039 | 16302 | ||||||
| 2025-12-19 | 4 | xslF345X05/ownership.xml | 0001171843-25-008038 | 15318 | ||||||
| 2025-12-19 | 4 | xslF345X05/ownership.xml | 0001171843-25-008037 | 15298 | ||||||
| 2025-12-19 | 4 | PRIMARY DOCUMENT | 0000882796-25-000038 | 6910 | ||||||
| 2025-12-18 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-003840 | 333-291678 | 251584859 | 33 | 1785 | ||
| 2025-12-18 | 424B3 | 424B3 | 0001140361-25-046040 | 333-291678 | 251583659 | 33 | 3747929 | |||
| 2025-12-16 | 4 | PRIMARY DOCUMENT | 0000882796-25-000036 | 4653 | ||||||
| 2025-12-16 | 4 | PRIMARY DOCUMENT | 0000882796-25-000033 | 6408 | ||||||
| 2025-12-16 | 4 | PRIMARY DOCUMENT | 0000882796-25-000031 | 6169 | ||||||
| 2025-12-16 | CORRESP | filename1.htm | 0001140361-25-045599 | 417959 | ||||||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007729 | 000-23186 | 251570370 | 33 | 6313 | |||
| 2025-12-15 | S-4/A | S-4/A | 0001140361-25-045461 | 333-291678 | 251570075 | 33 | 4641090 | |||
| 2025-12-12 | 8-K | FORM 8-K | 8.01,9.01 | 0001171843-25-007909 | 000-23186 | 251566586 | 34 | 260585 | 1 | 1 |
| 2025-12-11 | 8-K | FORM 8-K | 5.02 | 0001171843-25-007878 | 000-23186 | 251563515 | 34 | 186401 | 1 | 1 |
| 2025-12-03 | 4 | PRIMARY DOCUMENT | 0000882796-25-000027 | 12283 | ||||||
| 2025-12-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007471 | 000-23186 | 251546028 | 33 | 9445 | |||
| 2025-12-03 | 425 | 425 | 0001140361-25-044111 | 528505 | ||||||
| 2025-12-03 | 8-K | 8-K | 8.01,9.01 | 0001140361-25-044110 | 000-23186 | 251545029 | 34 | 668539 | 1 | 1 |
| 2025-12-02 | 4 | PRIMARY DOCUMENT | 0000882796-25-000023 | 4476 | ||||||
| 2025-12-02 | 4 | PRIMARY DOCUMENT | 0000882796-25-000021 | 4472 | ||||||
| 2025-12-02 | 4 | PRIMARY DOCUMENT | 0000882796-25-000019 | 4491 | ||||||
| 2025-12-02 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007427 | 000-23186 | 251542624 | 33 | 10198 | |||
| 2025-12-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007391 | 000-23186 | 251538633 | 33 | 4429 | |||
| 2025-11-25 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-054000 | 000-23186 | 251521782 | 33 | 5880 | |||
| 2025-11-21 | 144 | xsl144X01/primary_doc.xml | 0001628280-25-053613 | 000-23186 | 251508401 | 33 | 5352 | |||
| 2025-11-20 | S-4 | S-4 | 0001140361-25-042879 | 333-291678 | 251503940 | 33 | 4027279 | 1 | 1 | |
| 2025-11-17 | 4 | PRIMARY DOCUMENT | 0000882796-25-000017 | 4656 | ||||||
| 2025-11-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006976 | 000-23186 | 251476059 | 33 | 5099 | |||
| 2025-11-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-25-000052 | 005-44055 | 251475022 | 34 | 18781 | |||
| 2025-11-04 | 10-Q | 10-Q | 0001628280-25-048785 | 000-23186 | 251448845 | 34 | 13477245 | 1 | 1 | |
| 2025-11-03 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-25-006881 | 000-23186 | 251442099 | 34 | 386492 | 1 | 1 |
| 2025-10-14 | 425 | 425 | 0001140361-25-038091 | 62066 | ||||||
| 2025-10-14 | 425 | 425 | 0001140361-25-038088 | 497631 | ||||||
| 2025-10-14 | 425 | 425 | 0001140361-25-038086 | 17655 | ||||||
| 2025-10-14 | 425 | 425 | 0001140361-25-038032 | 4407104 | ||||||
| 2025-10-14 | 8-K | 8-K | 1.01,2.02,5.02,8.01,9.01 | 0001140361-25-038031 | 000-23186 | 251389592 | 34 | 4711459 | 1 | 1 |
| 2025-10-01 | 8-K | 8-K | 1.01,8.01,9.01 | 0001140361-25-036875 | 000-23186 | 251362619 | 34 | 1496563 | 1 | 1 |
| 2025-09-19 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193805-25-001316 | 005-44055 | 251325738 | 34 | 16622 | |||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0000882796-25-000013 | 4476 | ||||||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0000882796-25-000005 | 4472 | ||||||
| 2025-09-03 | 4 | PRIMARY DOCUMENT | 0000882796-25-000003 | 4491 | ||||||
| 2025-08-15 | 4 | PRIMARY DOCUMENT | 0001127602-25-020491 | 11757 | ||||||
| 2025-08-13 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-005151 | 000-23186 | 251210003 | 33 | 4883 | |||
| 2025-08-12 | S-8 | FORM S-8 | 0001171843-25-005329 | 333-289527 | 251206734 | 33 | 208907 | 1 | 1 | |
| 2025-08-11 | 8-K | FORM 8-K | 5.02 | 0001171843-25-005265 | 000-23186 | 251200141 | 34 | 187415 | 1 | 1 |
| 2025-08-05 | 10-Q | 10-Q | 0001628280-25-037795 | 000-23186 | 251184798 | 34 | 9157591 | 1 | 1 | |
| 2025-08-04 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-25-004977 | 000-23186 | 251177978 | 34 | 357042 | 1 | 1 |
| 2025-07-31 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-25-004869 | 000-23186 | 251169354 | 34 | 235630 | 1 | 1 |
| 2025-07-28 | 4 | PRIMARY DOCUMENT | 0001127602-25-019632 | 7162 | ||||||
| 2025-07-11 | 3 | xslF345X02/ownership.xml | 0001171843-25-004435 | 11966 | ||||||
| 2025-07-07 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-25-004324 | 000-23186 | 251106965 | 34 | 230617 | 1 | 1 |
| 2025-06-30 | 8-K | 8-K | 1.01,9.01 | 0001140361-25-024089 | 000-23186 | 251088764 | 34 | 2533420 | 1 | 1 |
| 2025-06-27 | 8-K | FORM 8-K | 8.01,9.01 | 0001171843-25-004186 | 000-23186 | 251082182 | 34 | 240643 | 1 | 1 |
| 2025-06-25 | 8-K | FORM 8-K | 8.01 | 0001171843-25-004091 | 000-23186 | 251070852 | 34 | 188472 | 1 | 1 |
| 2025-06-16 | 4 | xslF345X05/ownership.xml | 0001171843-25-003918 | 15167 | ||||||
| 2025-06-16 | 4 | xslF345X05/ownership.xml | 0001171843-25-003917 | 15243 | ||||||
| 2025-06-16 | 4 | xslF345X05/ownership.xml | 0001171843-25-003916 | 15133 | ||||||
| 2025-06-16 | 4 | xslF345X05/ownership.xml | 0001171843-25-003915 | 15121 | ||||||
| 2025-06-16 | 4 | xslF345X05/ownership.xml | 0001171843-25-003914 | 15126 | ||||||
| 2025-06-16 | 4 | xslF345X05/ownership.xml | 0001171843-25-003913 | 15154 | ||||||
| 2025-06-16 | 4 | xslF345X05/ownership.xml | 0001171843-25-003912 | 16168 | ||||||
| 2025-06-16 | 4 | xslF345X05/ownership.xml | 0001171843-25-003911 | 7257 | ||||||
| 2025-06-16 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-25-003910 | 000-23186 | 251050225 | 34 | 366984 | 1 | 1 |
| 2025-06-04 | 8-K | FORM 8-K | 5.02 | 0001171843-25-003662 | 000-23186 | 251021899 | 34 | 185557 | 1 | 1 |
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001127602-25-016424 | 4492 | ||||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001127602-25-016419 | 4479 | ||||||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-002355 | 005-44055 | 25949339 | 34 | 10546 | |||
| 2025-05-14 | 8-K | FORM 8-K | 8.01,9.01 | 0001171843-25-003152 | 000-23186 | 25942633 | 34 | 233639 | 1 | 1 |
| 2025-05-06 | 4 | PRIMARY DOCUMENT | 0001127602-25-013478 | 7086 | ||||||
| 2025-05-06 | 3 | xslF345X02/ownership.xml | 0001171843-25-002822 | 10235 | ||||||
| 2025-05-06 | 10-Q | 10-Q | 0001628280-25-022658 | 000-23186 | 25917125 | 34 | 8013686 | 1 | 1 | |
| 2025-05-05 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-25-002739 | 000-23186 | 25910861 | 34 | 287021 | 1 | 1 |
| 2025-05-01 | 8-K | FORM 8-K | 5.02,9.01 | 0001171843-25-002669 | 000-23186 | 25899383 | 34 | 226413 | 1 | 1 |
| 2025-04-24 | ARS | ARS | 0001140361-25-015469 | 000-23186 | 25867871 | 34 | 1726657 | |||
| 2025-04-24 | DEFA14A | DEFA14A | 0001140361-25-015459 | 000-23186 | 25867719 | 34 | 366185 | |||
| 2025-04-24 | DEF 14A | DEF 14A | 0001628280-25-019659 | 000-23186 | 25867194 | 34 | 3513020 | 1 | 1 | |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000567 | 005-44055 | 25844503 | 34 | 11093 | |||
| 2025-04-10 | 8-K | FORM 8-K | 5.02 | 0001171843-25-002147 | 000-23186 | 25828294 | 34 | 196293 | 1 | 1 |
| 2025-04-02 | 4 | PRIMARY DOCUMENT | 0001127602-25-011136 | 4699 | ||||||
| 2025-03-11 | 8-K | FORM 8-K | 8.01 | 0001171843-25-001383 | 000-23186 | 25725771 | 34 | 198615 | 1 | 1 |
| 2025-03-04 | 4 | PRIMARY DOCUMENT | 0001127602-25-007884 | 4497 | ||||||
| 2025-03-04 | 8-K | FORM 8-K | 5.02 | 0001171843-25-001231 | 000-23186 | 25701605 | 34 | 194476 | 1 | 1 |
| 2025-02-25 | 10-K | 10-K | 0001628280-25-007715 | 000-23186 | 25662920 | 34 | 11479410 | 1 | 1 | |
| 2025-02-24 | 8-K | FORM 8-K | 2.02,7.01,8.01,9.01 | 0001171843-25-001020 | 000-23186 | 25654167 | 34 | 347268 | 1 | 1 |
| 2025-01-13 | 8-K | FORM 8-K | 7.01 | 0001171843-25-000190 | 000-23186 | 25524780 | 34 | 194667 | 1 | 1 |
| 2025-01-10 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-25-000155 | 000-23186 | 25520389 | 34 | 232964 | 1 | 1 |
| 2025-01-08 | 8-K | FORM 8-K | 7.01 | 0001171843-25-000112 | 000-23186 | 25516581 | 34 | 193850 | 1 | 1 |
| 2024-12-23 | 4 | PRIMARY DOCUMENT | 0001127602-24-029971 | 8662 | ||||||
| 2024-12-23 | 4 | PRIMARY DOCUMENT | 0001127602-24-029969 | 8702 | ||||||
| 2024-12-23 | 4 | PRIMARY DOCUMENT | 0001127602-24-029965 | 8657 | ||||||
| 2024-12-23 | 4 | PRIMARY DOCUMENT | 0001127602-24-029952 | 8613 | ||||||
| 2024-12-23 | 4 | PRIMARY DOCUMENT | 0001127602-24-029948 | 13628 | ||||||
| 2024-12-17 | 4 | PRIMARY DOCUMENT | 0001127602-24-029602 | 4667 | ||||||
| 2024-12-17 | 4 | PRIMARY DOCUMENT | 0001127602-24-029592 | 6172 | ||||||
| 2024-12-17 | 4 | PRIMARY DOCUMENT | 0001127602-24-029582 | 4618 | ||||||
| 2024-12-17 | 4 | PRIMARY DOCUMENT | 0001127602-24-029573 | 4662 | ||||||
| 2024-12-17 | 4 | PRIMARY DOCUMENT | 0001127602-24-029566 | 4707 | ||||||
| 2024-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-24-029494 | 5221 | ||||||
| 2024-12-13 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000841 | 000-23186 | 241548701 | 33 | 4669 | |||
| 2024-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-24-028290 | 4498 | ||||||
| 2024-11-07 | SC 13G/A | UnitedStates_13G__BioCrystPh.txt | 0000932471-24-000792 | 005-44055 | 241433864 | 34 | 6599 | |||
| 2024-11-07 | SC 13G/A | UnitedStates_13G__BioCrystPh.txt | 0000932471-24-000791 | 005-44055 | 241433749 | 34 | 6600 | |||
| 2024-11-05 | 10-Q | 10-Q | 0001628280-24-045364 | 000-23186 | 241428562 | 34 | 8408708 | 1 | 1 | |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__BioCrystPh.txt | 0000932471-24-000298 | 005-44055 | 241421441 | 34 | 5640 | |||
| 2024-11-04 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-24-005975 | 000-23186 | 241420733 | 34 | 321101 | 1 | 1 |
| 2024-10-17 | SC 13G/A | BioCryst_Pharma_Inc.htm | 0000093751-24-000812 | 005-44055 | 241376608 | 34 | 56032 | |||
| 2024-10-02 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-24-005439 | 000-23186 | 241345265 | 34 | 223382 | 1 | 1 |
| 2024-09-30 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001171843-24-005393 | 000-23186 | 241336655 | 34 | 227094 | 1 | 1 |
| 2024-09-10 | SC 13G/A | us09058v1035_091024.txt | 0001086364-24-008614 | 005-44055 | 241289293 | 34 | 14143 | |||
| 2024-09-03 | 4 | PRIMARY DOCUMENT | 0001127602-24-023304 | 4498 | ||||||
| 2024-08-06 | S-8 | FORM S-8 | 0001171843-24-004489 | 333-281294 | 241179988 | 33 | 204468 | 1 | 1 | |
| 2024-08-06 | 10-Q | 10-Q | 0001628280-24-035170 | 000-23186 | 241179067 | 34 | 8208950 | 1 | 1 | |
| 2024-08-05 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-24-004422 | 000-23186 | 241173075 | 34 | 328629 | 1 | 1 |
| 2024-06-25 | 4 | PRIMARY DOCUMENT | 0001127602-24-019215 | 4991 | ||||||
| 2024-06-24 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000445 | 000-23186 | 241064400 | 33 | 4429 | |||
| 2024-06-17 | 4 | PRIMARY DOCUMENT | 0001127602-24-018846 | 5011 | ||||||
| 2024-06-17 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000419 | 000-23186 | 241048371 | 33 | 4461 | |||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018737 | 6947 | ||||||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018733 | 6942 | ||||||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018728 | 6927 | ||||||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018725 | 6939 | ||||||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018720 | 6914 | ||||||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018715 | 9075 | ||||||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018711 | 8206 | ||||||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018708 | 7601 | ||||||
| 2024-06-14 | 4 | PRIMARY DOCUMENT | 0001127602-24-018705 | 6971 | ||||||
| 2024-06-14 | 144 | xsl144X01/primary_doc.xml | 0001971857-24-000403 | 000-23186 | 241044797 | 33 | 4443 | |||
| 2024-06-13 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-24-003430 | 000-23186 | 241041563 | 34 | 372755 | 1 | 1 |
| 2024-06-03 | 4 | PRIMARY DOCUMENT | 0001127602-24-017302 | 4498 | ||||||
| 2024-06-03 | 4 | PRIMARY DOCUMENT | 0001127602-24-017295 | 4498 | ||||||
| 2024-05-31 | 4 | PRIMARY DOCUMENT | 0001127602-24-017121 | 4287 | ||||||
| 2024-05-29 | 4 | PRIMARY DOCUMENT | 0001127602-24-016776 | 4948 | ||||||
| 2024-05-22 | 4 | PRIMARY DOCUMENT | 0001127602-24-016190 | 4707 | ||||||
| 2024-05-22 | 4 | PRIMARY DOCUMENT | 0001127602-24-016188 | 4740 | ||||||
| 2024-05-15 | 4 | PRIMARY DOCUMENT | 0001127602-24-015373 | 4344 | ||||||
| 2024-05-15 | 4 | PRIMARY DOCUMENT | 0001127602-24-015371 | 4839 | ||||||
| 2024-05-15 | 4 | PRIMARY DOCUMENT | 0001127602-24-015369 | 4769 | ||||||
| 2024-05-15 | 4 | PRIMARY DOCUMENT | 0001127602-24-015367 | 4749 | ||||||
| 2024-05-15 | 4 | PRIMARY DOCUMENT | 0001127602-24-015365 | 6303 | ||||||
| 2024-05-15 | 4 | PRIMARY DOCUMENT | 0001127602-24-015363 | 4349 | ||||||
| 2024-05-07 | 10-Q | 10-Q | 0001628280-24-021069 | 000-23186 | 24921671 | 34 | 7414985 | 1 | 1 | |
| 2024-05-06 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-24-002550 | 000-23186 | 24915508 | 34 | 282331 | 1 | 1 |
| 2024-04-25 | ARS | ARS | 0001140361-24-022074 | 000-23186 | 24876779 | 34 | 1772530 | |||
| 2024-04-25 | DEFA14A | DEFA14A | 0001140361-24-022065 | 000-23186 | 24876731 | 34 | 444589 | |||
| 2024-04-25 | DEF 14A | DEF 14A | 0001628280-24-018175 | 000-23186 | 24876528 | 34 | 3346831 | 1 | 1 | |
| 2024-04-02 | 4 | PRIMARY DOCUMENT | 0001127602-24-011832 | 4706 | ||||||
| 2024-03-04 | 4 | PRIMARY DOCUMENT | 0001127602-24-008156 | 4497 | ||||||
| 2024-03-04 | 4 | PRIMARY DOCUMENT | 0001127602-24-008140 | 4497 | ||||||
| 2024-02-27 | S-3ASR | S-3ASR | 0001140361-24-009789 | 333-277417 | 24688219 | 33 | 1238536 | |||
| 2024-02-27 | 10-K | 10-K | 0001628280-24-007205 | 000-23186 | 24686601 | 34 | 11449132 | 1 | 1 | |
| 2024-02-26 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-24-000967 | 000-23186 | 24673522 | 34 | 315644 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023745 | 005-44055 | 24638760 | 34 | 88718 | |||
| 2024-02-14 | SC 13G | BIOCRYST PHARMACEUTICALS INC. | 0000902664-24-001592 | 005-44055 | 24632866 | 34 | 62842 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020432 | 005-44055 | 24627590 | 34 | 13111 | |||
| 2024-01-24 | SC 13G/A | us09058v1035_012424.txt | 0001086364-24-002734 | 005-44055 | 24557831 | 34 | 13728 | |||
| 2024-01-24 | SC 13G/A | BioCryst_Ph_Inc.txt | 0000093751-24-000174 | 005-44055 | 24555473 | 34 | 8547 | |||
| 2024-01-18 | 8-K | FORM 8-K | 5.03,9.01 | 0001171843-24-000297 | 000-23186 | 24542818 | 34 | 384441 | 1 | 1 |
| 2024-01-08 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-24-000112 | 000-23186 | 24518282 | 34 | 231184 | 1 | 1 |
| 2024-01-04 | 4 | PRIMARY DOCUMENT | 0001127602-24-000832 | 7891 | ||||||
| 2023-12-20 | 4 | PRIMARY DOCUMENT | 0001127602-23-030189 | 4707 | ||||||
| 2023-12-20 | 4 | PRIMARY DOCUMENT | 0001127602-23-030187 | 6172 | ||||||
| 2023-12-20 | 4 | PRIMARY DOCUMENT | 0001127602-23-030185 | 4667 | ||||||
| 2023-12-20 | 4 | PRIMARY DOCUMENT | 0001127602-23-030181 | 4662 | ||||||
| 2023-12-20 | 4 | PRIMARY DOCUMENT | 0001127602-23-030177 | 4618 | ||||||
| 2023-12-18 | 4 | PRIMARY DOCUMENT | 0001127602-23-029839 | 8701 | ||||||
| 2023-12-18 | 4 | PRIMARY DOCUMENT | 0001127602-23-029835 | 10168 | ||||||
| 2023-12-18 | 4 | PRIMARY DOCUMENT | 0001127602-23-029833 | 8661 | ||||||
| 2023-12-18 | 4 | PRIMARY DOCUMENT | 0001127602-23-029831 | 8656 | ||||||
| 2023-12-18 | 4 | PRIMARY DOCUMENT | 0001127602-23-029829 | 8612 | ||||||
| 2023-12-01 | 4 | PRIMARY DOCUMENT | 0001127602-23-028609 | 4416 | ||||||
| 2023-12-01 | 4 | PRIMARY DOCUMENT | 0001127602-23-028607 | 4416 | ||||||
| 2023-12-01 | 8-K | FORM 8-K | 5.02 | 0001171843-23-007377 | 000-23186 | 231457550 | 34 | 191261 | 1 | 1 |
| 2023-11-30 | 8-K | FORM 8-K | 7.01 | 0001171843-23-007357 | 000-23186 | 231454085 | 34 | 193211 | 1 | 1 |
| 2023-11-08 | S-8 | FORM S-8 | 0001171843-23-006869 | 333-275401 | 231388338 | 33 | 143665 | |||
| 2023-11-08 | 10-Q | 10-Q | 0001628280-23-037847 | 000-23186 | 231387970 | 34 | 7850107 | 1 | 1 | |
| 2023-11-03 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-23-006717 | 000-23186 | 231375201 | 34 | 237580 | 1 | 1 |
| 2023-11-03 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-23-006716 | 000-23186 | 231375192 | 34 | 231205 | 1 | 1 |
| 2023-11-02 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-23-006627 | 000-23186 | 231370018 | 34 | 303664 | 1 | 1 |
| 2023-10-26 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-23-006441 | 000-23186 | 231347742 | 34 | 224593 | 1 | 1 |
| 2023-09-05 | 4 | PRIMARY DOCUMENT | 0001127602-23-023695 | 4416 | ||||||
| 2023-09-05 | 4 | PRIMARY DOCUMENT | 0001127602-23-023693 | 4416 | ||||||
| 2023-08-07 | 10-Q | 10-Q | 0001628280-23-027820 | 000-23186 | 231148274 | 34 | 8618316 | 1 | 1 | |
| 2023-08-03 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-23-004942 | 000-23186 | 231138007 | 34 | 304294 | 1 | 1 |
| 2023-07-11 | 8-K | FORM 8-K | 5.02 | 0001171843-23-004444 | 000-23186 | 231081191 | 34 | 195103 | 1 | 1 |
| 2023-06-30 | S-8 | S-8 | 0001171843-23-004273 | 333-273042 | 231059440 | 33 | 192817 | |||
| 2023-06-15 | 4 | xslF345X04/ownership.xml | 0001171843-23-003946 | 6187 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018793 | 6846 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018791 | 6892 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018788 | 6878 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018786 | 6824 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018783 | 8276 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018779 | 6849 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018775 | 8686 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018771 | 6834 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018767 | 6849 | ||||||
| 2023-06-15 | 4 | PRIMARY DOCUMENT | 0001127602-23-018765 | 6878 | ||||||
| 2023-06-15 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000276 | 000-23186 | 231016228 | 33 | 4191 | |||
| 2023-06-14 | 144 | xsl144X01/primary_doc.xml | 0001971857-23-000265 | 000-23186 | 231013422 | 33 | 4150 | |||
| 2023-06-14 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-23-003914 | 000-23186 | 231012985 | 34 | 385237 | 1 | 1 |
| 2023-06-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-017562 | 4415 | ||||||
| 2023-06-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-017556 | 4402 | ||||||
| 2023-06-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-017552 | 4415 | ||||||
| 2023-05-08 | 10-Q | 10-Q | 0001628280-23-016458 | 000-23186 | 23898334 | 34 | 6757940 | 1 | 1 | |
| 2023-05-03 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-23-002790 | 000-23186 | 23881641 | 34 | 263715 | 1 | 1 |
| 2023-04-27 | ARS | FORM ARS | 0001140361-23-020956 | 000-23186 | 23857272 | 34 | 1268964 | |||
| 2023-04-27 | DEFA14A | DEFA14A | 0001140361-23-020953 | 000-23186 | 23857245 | 34 | 4933165 | |||
| 2023-04-27 | DEF 14A | DEF 14A | 0001140361-23-020945 | 000-23186 | 23857190 | 34 | 8102125 | 1 | 1 | |
| 2023-04-18 | 8-K | FORM 8-K | 1.01,2.03,7.01,9.01 | 0001171843-23-002355 | 000-23186 | 23825462 | 34 | 235456 | 1 | 1 |
| 2023-04-05 | 4 | PRIMARY DOCUMENT | 0001127602-23-012587 | 5241 | ||||||
| 2023-03-23 | 4 | PRIMARY DOCUMENT | 0001127602-23-011193 | 8312 | ||||||
| 2023-03-13 | 8-K | FORM 8-K | 7.01 | 0001171843-23-001614 | 000-23186 | 23725646 | 34 | 195088 | 1 | 1 |
| 2023-03-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-008400 | 4379 | ||||||
| 2023-03-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-008391 | 4473 | ||||||
| 2023-03-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-008383 | 4379 | ||||||
| 2023-03-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-008381 | 4366 | ||||||
| 2023-02-27 | 10-K | 10-K | 0001628280-23-005259 | 000-23186 | 23675662 | 34 | 10901344 | 1 | 1 | |
| 2023-02-21 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-23-001058 | 000-23186 | 23645232 | 34 | 334901 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021487 | 005-44055 | 23628456 | 34 | 104846 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015458 | 005-44055 | 23602605 | 34 | 13030 | |||
| 2023-02-06 | SC 13G/A | BioCryst_Pharmaceuticals_Inc.txt | 0000093751-23-000212 | 005-44055 | 23588865 | 34 | 8508 | |||
| 2023-02-03 | SC 13G/A | us09058v1035_020323.txt | 0001306550-23-007838 | 005-44055 | 23586405 | 34 | 13466 | |||
| 2023-02-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-003172 | 14075 | ||||||
| 2023-02-02 | 4 | PRIMARY DOCUMENT | 0001127602-23-003163 | 6793 | ||||||
| 2023-01-09 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-23-000154 | 000-23186 | 23516536 | 34 | 242355 | 1 | 1 |
| 2022-12-21 | 4 | PRIMARY DOCUMENT | 0001127602-22-028084 | 6763 | ||||||
| 2022-12-21 | 4 | PRIMARY DOCUMENT | 0001127602-22-028082 | 6852 | ||||||
| 2022-12-21 | 4 | PRIMARY DOCUMENT | 0001127602-22-028080 | 8315 | ||||||
| 2022-12-21 | 4 | PRIMARY DOCUMENT | 0001127602-22-028078 | 6809 | ||||||
| 2022-12-21 | 4 | PRIMARY DOCUMENT | 0001127602-22-028076 | 6812 | ||||||
| 2022-12-21 | 4 | PRIMARY DOCUMENT | 0001127602-22-028074 | 6807 | ||||||
| 2022-12-19 | 4 | PRIMARY DOCUMENT | 0001127602-22-027894 | 6675 | ||||||
| 2022-12-19 | 4 | PRIMARY DOCUMENT | 0001127602-22-027887 | 5213 | ||||||
| 2022-12-19 | 4 | PRIMARY DOCUMENT | 0001127602-22-027883 | 5168 | ||||||
| 2022-12-19 | 4 | PRIMARY DOCUMENT | 0001127602-22-027875 | 5173 | ||||||
| 2022-12-19 | 4 | PRIMARY DOCUMENT | 0001127602-22-027870 | 5175 | ||||||
| 2022-12-19 | 4 | PRIMARY DOCUMENT | 0001127602-22-027858 | 5124 | ||||||
| 2022-12-15 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001171843-22-008057 | 000-23186 | 221463632 | 34 | 229043 | 1 | 1 |
| 2022-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-026834 | 8221 | ||||||
| 2022-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-026832 | 15739 | ||||||
| 2022-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-026830 | 4381 | ||||||
| 2022-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-026828 | 4381 | ||||||
| 2022-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-026825 | 4367 | ||||||
| 2022-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-026823 | 4474 | ||||||
| 2022-11-16 | 4 | PRIMARY DOCUMENT | 0001127602-22-025761 | 12071 | ||||||
| 2022-11-04 | 10-Q | 10-Q | 0001628280-22-028463 | 000-23186 | 221362587 | 34 | 7547783 | 1 | 1 | |
| 2022-11-01 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-22-006936 | 000-23186 | 221348469 | 34 | 308458 | 1 | 1 |
| 2022-09-14 | 8-K | FORM 8-K | 5.02,7.01,9.01 | 0001171843-22-006097 | 000-23186 | 221243098 | 34 | 220718 | 1 | 1 |
| 2022-09-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-022018 | 4381 | ||||||
| 2022-09-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-022014 | 4367 | ||||||
| 2022-09-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-022009 | 4474 | ||||||
| 2022-09-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-022003 | 4381 | ||||||
| 2022-08-31 | S-8 | FORM S-8 | 0001171843-22-005878 | 333-267193 | 221218332 | 33 | 153237 | |||
| 2022-08-25 | 8-K | FORM 8-K | 7.01,8.01,9.01 | 0001171843-22-005818 | 000-23186 | 221192952 | 34 | 6314344 | 1 | 1 |
| 2022-08-05 | 10-Q | 10-Q | 0001628280-22-021373 | 000-23186 | 221141179 | 34 | 7665566 | 1 | 1 | |
| 2022-08-04 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-22-005341 | 000-23186 | 221134610 | 34 | 294481 | 1 | 1 |
| 2022-07-14 | S-8 | S-8 | 0001171843-22-004859 | 333-266132 | 221083373 | 33 | 103013 | |||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017169 | 6823 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017167 | 6818 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017165 | 6921 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017163 | 6784 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017160 | 6803 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017157 | 6818 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017153 | 6847 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017148 | 6815 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017144 | 6861 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017141 | 6847 | ||||||
| 2022-06-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-017138 | 6793 | ||||||
| 2022-06-07 | 8-K | FORM 8-K | 5.02,5.07,9.01 | 0001171843-22-004206 | 000-23186 | 221001749 | 34 | 374879 | 1 | 1 |
| 2022-06-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-016409 | 4452 | ||||||
| 2022-06-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-016402 | 4467 | ||||||
| 2022-06-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-016395 | 4463 | ||||||
| 2022-06-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-016390 | 4570 | ||||||
| 2022-05-26 | DEFA14A | DEFA14A | 0001140361-22-020820 | 000-23186 | 22971072 | 34 | 76723 | |||
| 2022-05-09 | 10-Q | FORM 10-Q | 0001171843-22-003423 | 000-23186 | 22903196 | 34 | 6582077 | 1 | 1 | |
| 2022-05-05 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-22-003265 | 000-23186 | 22893989 | 34 | 271915 | 1 | 1 |
| 2022-04-25 | DEFA14A | DEFA14A | 0001140361-22-015747 | 000-23186 | 22850081 | 34 | 6085480 | |||
| 2022-04-25 | DEF 14A | DEF14A | 0001140361-22-015743 | 000-23186 | 22850051 | 34 | 3154101 | |||
| 2022-04-20 | 4 | PRIMARY DOCUMENT | 0001127602-22-012272 | 8126 | ||||||
| 2022-04-11 | 8-K | FORM 8-K | 7.01 | 0001171843-22-002497 | 000-23186 | 22818507 | 34 | 198710 | 1 | 1 |
| 2022-04-08 | 8-K | FORM 8-K | 8.01,9.01 | 0001171843-22-002466 | 000-23186 | 22815566 | 34 | 219071 | 1 | 1 |
| 2022-04-04 | 4 | PRIMARY DOCUMENT | 0001127602-22-011188 | 5117 | ||||||
| 2022-03-14 | 4 | PRIMARY DOCUMENT | 0001127602-22-009124 | 10070 | ||||||
| 2022-03-09 | 4 | PRIMARY DOCUMENT | 0001127602-22-008780 | 4664 | ||||||
| 2022-03-03 | 4 | PRIMARY DOCUMENT | 0001127602-22-008047 | 7753 | ||||||
| 2022-03-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-007730 | 4365 | ||||||
| 2022-03-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-007725 | 4473 | ||||||
| 2022-03-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-007722 | 4369 | ||||||
| 2022-03-02 | 4 | PRIMARY DOCUMENT | 0001127602-22-007717 | 4355 | ||||||
| 2022-02-28 | 10-K | FORM 10-K | 0001171843-22-001460 | 000-23186 | 22690938 | 34 | 12506576 | 1 | 1 | |
| 2022-02-23 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-22-001277 | 000-23186 | 22660582 | 34 | 319416 | 1 | 1 |
| 2022-02-22 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-22-001239 | 000-23186 | 22654924 | 34 | 224250 | 1 | 1 |
| 2022-02-17 | 8-K | FORM 8-K | 7.01 | 0001171843-22-001136 | 000-23186 | 22648058 | 34 | 193814 | 1 | 1 |
| 2022-02-16 | 4 | PRIMARY DOCUMENT | 0001127602-22-005295 | 8566 | ||||||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022834 | 005-44055 | 22632142 | 34 | 91780 | |||
| 2022-02-10 | 4 | xslF345X03/ownership.xml | 0001171843-22-000942 | 5443 | ||||||
| 2022-02-10 | 3 | xslF345X02/ownership.xml | 0001171843-22-000941 | 11158 | ||||||
| 2022-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-016640 | 005-44055 | 22606656 | 34 | 13023 | |||
| 2022-02-09 | SC 13G/A | BIOCRYST_PHARMACEUTICALS_INC.txt | 0000093751-22-000019 | 005-44055 | 22605153 | 34 | 8465 | |||
| 2022-02-08 | 8-K | FORM 8-K | 5.02,9.01 | 0001171843-22-000840 | 000-23186 | 22599286 | 34 | 223842 | 1 | 1 |
| 2022-02-01 | SC 13G/A | us09058v1035_020122.txt | 0000834237-22-004595 | 005-44055 | 22580028 | 34 | 13466 | |||
| 2022-01-18 | UPLOAD | filename1.pdf | 0000000000-22-000611 | 39676 | ||||||
| 2022-01-14 | CORRESP | filename1.htm | 0001171843-22-000275 | 36942 | ||||||
| 2022-01-13 | 4 | PRIMARY DOCUMENT | 0001127602-22-001458 | 10111 | ||||||
| 2022-01-13 | 4/A | PRIMARY DOCUMENT | 0001127602-22-001456 | 4690 | ||||||
| 2022-01-13 | 4/A | PRIMARY DOCUMENT | 0001127602-22-001454 | 4695 | ||||||
| 2022-01-13 | 4/A | PRIMARY DOCUMENT | 0001127602-22-001452 | 4646 | ||||||
| 2022-01-10 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-22-000172 | 000-23186 | 22519647 | 34 | 237078 | 1 | 1 |
| 2022-01-07 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-22-000150 | 000-23186 | 22516715 | 34 | 224384 | 1 | 1 |
| 2021-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-21-031141 | 6816 | ||||||
| 2021-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-21-031137 | 6832 | ||||||
| 2021-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-21-031134 | 6802 | ||||||
| 2021-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-21-031130 | 6856 | ||||||
| 2021-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-21-031126 | 6767 | ||||||
| 2021-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-21-031121 | 6812 | ||||||
| 2021-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-21-031118 | 6801 | ||||||
| 2021-12-16 | 4 | PRIMARY DOCUMENT | 0001127602-21-031116 | 13460 | ||||||
| 2021-12-14 | UPLOAD | filename1.pdf | 0000000000-21-014940 | 43166 | ||||||
| 2021-12-09 | 4 | PRIMARY DOCUMENT | 0001127602-21-030610 | 8208 | ||||||
| 2021-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-21-030063 | 4356 | ||||||
| 2021-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-21-030059 | 4366 | ||||||
| 2021-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-21-030052 | 4370 | ||||||
| 2021-12-02 | 4 | PRIMARY DOCUMENT | 0001127602-21-030043 | 4474 | ||||||
| 2021-11-29 | 8-K | FORM 8-K | 7.01,9.01 | 0001171843-21-008198 | 000-23186 | 211452990 | 34 | 224035 | 1 | 1 |
| 2021-11-24 | 4 | xslF345X03/ownership.xml | 0001171843-21-008177 | 4435 | ||||||
| 2021-11-24 | 4 | xslF345X03/ownership.xml | 0001171843-21-008176 | 4447 | ||||||
| 2021-11-22 | 8-K | FORM 8-K | 1.01,2.03,3.02 | 0001171843-21-008117 | 000-23186 | 211430137 | 34 | 223443 | 1 | 1 |
| 2021-11-17 | 4 | PRIMARY DOCUMENT | 0001127602-21-029440 | 8568 | ||||||
| 2021-11-04 | 10-Q | FORM 10-Q | 0001171843-21-007570 | 000-23186 | 211380546 | 34 | 6792927 | 1 | 1 | |
| 2021-11-03 | 8-K | FORM 8-K | 2.02,7.01,9.01 | 0001171843-21-007423 | 000-23186 | 211373672 | 34 | 304132 | 1 | 1 |
One latest value per concept from companyfacts (430 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 257.30M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 1.86B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 596.12M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026822 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 3.09M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026822 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 5.69M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026822 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 200.89 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026822 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 1.16M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026822 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 12.95M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026822 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 104.7 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001628280-26-026822 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 8,787.3 | 2026-08-04 | S-8 | 2026-08-05 | 0001171843-26-005245 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 8,787.3 | 2026-08-04 | S-8 | 2026-08-05 | 0001171843-26-005245 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 63.63M | 2026-08-04 | S-8 | 2026-08-05 | 0001171843-26-005245 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-04 | S-8 | 2026-08-05 | 0001171843-26-005245 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 14.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 121.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 110.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 11.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 9.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -607,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.71B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 546.70M | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-08 | 0001171843-15-002688 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 4,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 14.24M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 14.82M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 13.82M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 44.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | AllocatedShareBasedCompensationExpenseNetOfTax | Share-based Payment Arrangement, Expense, after Tax | USD | 1.61M | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192102 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 898,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-08 | 0001628280-23-016458 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 600,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 16.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 32,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001171843-16-008207 | |
| us-gaap | Assets | Assets | USD | 591.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 531.15M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 333.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 7,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 329,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 215.13M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-04 | 0001628280-22-028463 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 105.41M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 1,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 244,000 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 105.24M | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 278.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 278.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 216.14M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 3.00M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-06 | 0001171843-20-007740 | |
| us-gaap | AvailableForSaleSecuritiesFairValueDisclosure | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | USD | 13.46M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-09 | 0001193125-13-210965 | |
| us-gaap | AvailableforsaleSecuritiesGrossUnrealizedGain | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) | USD | 15,000 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-09 | 0001193125-13-210965 | |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedGains | Available-for-sale Securities, Gross Unrealized Gain | USD | 36,000 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-08 | 0001171843-15-002688 |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLoss | Available-for-sale Securities, Gross Unrealized Loss | USD | 27,000 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-08 | 0001171843-15-002688 |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLosses1 | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | USD | 12,000 | 2011-12-31 | 2012 | FY | 10-K | 2013-03-11 | 0001193125-13-100999 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 608,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001628280-26-031238 |
| us-gaap | CapitalLeaseObligationsCurrent | Capital Lease Obligations, Current | USD | 47,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 96.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 55.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 28.18M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 98.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 106.88M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-06 | 0001628280-25-022658 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 7.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations | USD | 7.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.01 | 2019-11-21 | 2021 | FY | 10-K | 2022-02-28 | 0001171843-22-001460 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 11.77M | 2019-11-21 | 2021 | FY | 10-K | 2022-02-28 | 0001171843-22-001460 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 69.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 450.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 256.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 256.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -606.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 10.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 11.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 10.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 1.14M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 1.10B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 238,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001171843-20-001710 | |
| us-gaap | CurrentFederalStateAndLocalTaxExpenseBenefit | Current Federal, State and Local, Tax Expense (Benefit) | USD | 1.12M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 1.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 4.74M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 3.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 11.93M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-08 | 0001628280-23-016458 | |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | USD | 695,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss | USD | 277.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 243.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | security | 30 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | DeferredCostsCurrent | Deferred Costs, Current | USD | 9,000 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-09 | 0001171843-19-003220 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | DeferredFederalStateAndLocalTaxExpenseBenefit | Deferred Federal, State and Local, Tax Expense (Benefit) | USD | 79,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 34,000 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-09 | 0001171843-22-003423 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | -1.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -1.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 3.58M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 54,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001171843-20-001710 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001628280-24-007205 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 8.18M | 2016-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | -184,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 1.85M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 384.35M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 40.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxAssetsInventory | Deferred Tax Assets, Inventory | USD | 1.61M | 2013-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001171843-15-001186 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 252,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 119.94M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 82.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 26.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 1.05M | 2015-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 85.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 40.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves | USD | 1.61M | 2013-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 | |
| us-gaap | DeferredTaxAssetsUnrealizedCurrencyLosses | Deferred Tax Assets, Unrealized Currency Losses | USD | -2.29M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001171843-15-001186 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 380.52M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 11,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001628280-24-007205 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 1.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains | Deferred Tax Liabilities, Unrealized Currency Transaction Gains | USD | 231,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001171843-20-001710 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 5.76M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | Depreciation | Depreciation | USD | 1.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 1.90M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-08 | 0001171843-16-013033 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Assets, Noncurrent | USD | 972,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -2.41 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1,030 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001171843-22-001460 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.41 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.2 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0.02 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.02 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.01 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | 71,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001171843-22-001460 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -101,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 50.86M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount | Share-based Payment Arrangement, Amount Capitalized | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 111.80M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001628280-23-037847 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 0 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-07 | 0001171843-14-005367 | |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions | Employee Service Share-based Compensation, Tax Benefit Realized from Exercise of Stock Options (Deprecated 2017-01-31) | USD | 15.65M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs | USD | 12.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 164,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | FinanceLeaseInterestPaymentOnLiability | Finance Lease, Interest Payment on Liability | USD | 164,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 1.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 623,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 1.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueAfterYearFive | Finance Lease, Liability, to be Paid, after Year Five | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 991,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFive | Finance Lease, Liability, to be Paid, Year Five | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 26,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 458,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 325,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 154,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 1.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 2.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | FinanceLeaseRightOfUseAssetAccumulatedAmortization | Finance Lease, Right-of-Use Asset, Accumulated Amortization | USD | 3.80M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 1.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.101 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | ForeignCurrencyDerivativeLiabilitiesAtFairValue | Foreign Currency Derivative Liabilities at Fair Value (Deprecated 2014-01-31) | USD | 981,000 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192102 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | -7,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001171843-21-001411 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -7,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 |
| us-gaap | GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments | Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments | USD | -176,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | GainLossOnForeignCurrencyFairValueHedgeDerivatives | Gain (Loss) on Foreign Currency Fair Value Hedge Derivatives | USD | 1.53M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460637 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | 3.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | GainLossOnSaleOfOtherAssets | Gain (Loss) on Disposition of Other Assets | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -93,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 10.33M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001171843-15-006102 |
| us-gaap | ImpairmentOfLongLivedAssetsToBeDisposedOf | Impairment of Long-Lived Assets to be Disposed of | USD | 9.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | 172.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -602.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 94.75M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -182.81M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001171843-21-001411 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 2.22M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-04 | 0001628280-25-048785 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 3.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 2.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability | Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability | USD | 73.47M | 2017-12-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001171843-20-001710 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | -52.45M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 2.35M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | 56.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | 3.72M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 1.28M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 4.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 4.93M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 2.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | -217,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | -1.21M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 1.32M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -45.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | 3.40M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-08 | 0001171843-15-002688 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 7.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -7.10M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001171843-18-007788 |
| us-gaap | IncreaseDecreaseInDerivativeAssets | Increase (Decrease) in Derivative Assets | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001628280-24-007205 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 16.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -2.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | 12.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 1.74M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 |
| us-gaap | IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements | Incremental Common Shares Attributable to Dilutive Effect of Equity Unit Purchase Agreements | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | InterestAndDebtExpense | Interest and Debt Expense | USD | 4.67M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-03-11 | 0001193125-13-100999 |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 7.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | InterestExpense | Interest Expense | USD | 49.24M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-06 | 0001628280-24-035170 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 56.31M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-07 | 0001628280-23-027820 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 62.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 22.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 21.67M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001171843-22-001460 | |
| us-gaap | InventoryAdjustments | Inventory Adjustments | USD | 170,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001628280-23-037847 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 5.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 416,000 | 2014-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001171843-16-008207 | |
| us-gaap | InventoryGross | Inventory, Gross | USD | 46.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 13.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 31.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 10.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | InventoryRawMaterialsAndSupplies | Inventory, Raw Materials and Supplies, Gross | USD | 263,000 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 206,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-06 | 0001171843-20-007740 | |
| us-gaap | InventoryValuationReserves | Inventory Valuation Reserves | USD | 1.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 29.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 6.04M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-06 | 0001171843-20-007740 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 443,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | Investments | Investments | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001171843-21-007570 | |
| us-gaap | InvestmentsAndCash | Investments and Cash | USD | 68.70M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-08 | 0001171843-16-013033 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 11.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 7.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 3.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 791,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.79M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | Liabilities | Liabilities | USD | 988.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 591.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 195.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LiabilitiesSubjectToCompromiseEarlyContractTerminationFees | Liabilities Subject to Compromise, Early Contract Termination Fees | USD | 10.00M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460637 | |
| us-gaap | LineOfCredit | Long-term Line of Credit | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001171843-21-001411 | |
| us-gaap | LinesOfCreditCurrent | Line of Credit, Current | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001171843-21-001411 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 298.14M | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001628280-24-007205 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 20.00M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-06 | 0001171843-20-007740 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 1.00M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001171843-18-007788 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 20.00M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-08 | 0001171843-19-007384 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 20.00M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001171843-20-003557 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 20.00M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-06 | 0001171843-20-007740 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 5.00M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-06 | 0001171843-20-007740 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 395.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | LongTermNotesPayable | Notes Payable, Noncurrent | USD | 30.00M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001171843-15-006102 | |
| us-gaap | LossOnContractTermination | Loss on Contract Termination | USD | 440,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | LossOnSaleOfInvestments | Loss on Sale of Investments | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 389.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 48.82M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001171843-17-004830 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -457.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -13.03M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001171843-17-004830 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 75.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -18.19M | 2017-01-01 | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-08 | 0001171843-17-004830 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -605.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 | Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) | USD | 251.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -52.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | NontradeReceivablesCurrent | Nontrade Receivables, Current | USD | 2.37M | 2013-09-30 | 2013 | Q3 | 10-Q | 2013-11-08 | 0001193125-13-434942 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 30.00M | 2020-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001171843-22-001460 | |
| us-gaap | NotionalAmountOfNetInvestmentHedgingInstruments | Notional Amount of Net Investment Hedging Instruments (Deprecated 2013-01-31) | USD | 5.95M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460637 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -549.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 2.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 9.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 2.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 6.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 7.55M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 5.25M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.30M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 503,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 491,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 524,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 934,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 1.50M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 758,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.083 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 2.42M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 20.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | USD | -73,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -572,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -566,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0001628280-24-021069 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -645,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 786,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0001628280-24-045364 |
| us-gaap | OtherIncome | Other Income | USD | 12.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | OtherInventorySupplies | Other Inventory, Supplies, Gross | USD | 263,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001171843-15-001186 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 3.54M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-08 | 0001171843-19-007384 | |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 2.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 7.14M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-08 | 0001628280-23-016458 |
| us-gaap | PaymentsForHedgeFinancingActivities | Payments for Hedge, Financing Activities | USD | 2.19M | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-08 | 0001171843-17-006746 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 61,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 64,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | PaymentsOfDebtExtinguishmentCosts | Payment for Debt Extinguishment or Debt Prepayment Cost | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 4.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 34,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | PaymentsOfLoanCosts | Payments of Loan Costs | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | -17.81M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460637 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 6.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 3.67M | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-08 | 0001193125-12-218117 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 275.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 489.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | PaymentsToAcquireProductiveAssets | Payments to Acquire Productive Assets | USD | 845,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 343,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-13 | 0001171843-20-001710 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 20.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | ProceedsFromCollaborators | Proceeds from Collaborators | USD | 6.92M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001171843-21-007570 |
| us-gaap | ProceedsFromDivestitureOfBusinessesNetOfCashDivested | Proceeds from Divestiture of Businesses, Net of Cash Divested | USD | -6.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001628280-24-007205 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 400.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ProceedsFromIssuanceOfSecuredDebt | Proceeds from Issuance of Secured Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 29.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 108.10M | 2020-06-01 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 73.07M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 308.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ProceedsFromSaleOfFurnitureAndFixtures | Proceeds from Sale of Furniture and Fixtures | USD | 12,000 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 |
| us-gaap | ProceedsFromSaleOfOtherAssetsInvestingActivities | Proceeds from Sale of Other Assets, Investing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 67,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 8.52M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0001628280-23-037847 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 300,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-08 | 0001171843-16-013033 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 18.18M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 1.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 1.00M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-05 | 0001628280-24-045364 | |
| us-gaap | ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | RepaymentsOfLinesOfCredit | Repayments of Lines of Credit | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | RepaymentsOfLongTermLinesOfCredit | Repayments of Long-term Lines of Credit | USD | 3.45M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001171843-18-005928 |
| us-gaap | RepaymentsOfSecuredDebt | Repayments of Secured Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 170.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 1.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 518,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 1.79M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-06 | 0001628280-26-031238 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | -97,000 | 2013-01-01 | 2013-12-31 | 2014 | FY | 10-K | 2015-03-02 | 0001171843-15-001186 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 6.31M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | RestructuringReserveAcceleratedDepreciation | Restructuring and Related Cost, Accelerated Depreciation | USD | 890,000 | 2010-10-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-03-11 | 0001193125-13-100999 |
| us-gaap | RestructuringReserveAccrualAdjustment | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) | USD | 97,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 |
| us-gaap | RestructuringReserveSettledWithCash | Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) | USD | 1.30M | 2013-01-01 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-09 | 0001193125-13-210965 |
| us-gaap | RetailLandSaleReceivablesWeightedAverageInterestRate | Retail Land Sale Receivables, Weighted Average Interest Rate (Deprecated 2016-01-31) | pure | 0.02 | 2011-06-01 | 2011-06-30 | 2014 | Q2 | 10-Q | 2014-08-08 | 0001171843-14-003839 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -2.11B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 554.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | Revenues | Revenues | USD | 25.19M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 4.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 126,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001171843-21-001411 |
| us-gaap | RoyaltyRevenue | Royalty Revenue (Deprecated 2018-01-31) | USD | 10.54M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 5.23 | 2012-03-15 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 | |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 1.50M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 25.19M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 225.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 44.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number | shares | 582,084 | 2021-08-01 | 2021-08-09 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001171843-21-007570 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 | Share-based Payment Arrangement, Expensed and Capitalized, Amount | USD | 44.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 22,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 34,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments | USD | 0 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-08 | 0001171843-14-003839 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.82 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.014 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | shares | 3.80M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 2.27M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 22.89M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 832,000 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192102 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 6.55 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 717,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 10.78 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 1.53M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 2.25M | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 7.60M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 8.03 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 17.69M | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | USD/shares | 6.24 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 7.02 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 12.10M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 4.99 | 2013-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 15.93M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 6.43 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-14 | 0001171843-19-001727 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | USD | 9.31M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-12 | 0001171843-18-001855 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 5.91M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 5.68 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease | Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) | shares | 3.75M | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001171843-16-008207 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased | Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased | USD/shares | 1.37 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192102 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 8.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.63 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 7.22 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 3.2 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-02-27 | 0001171843-17-001159 |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | USD/shares | 7.17 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | USD/shares | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares | 18,828 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 36,520 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 | Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price | USD/shares | 8.59 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | USD/shares | 18 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 |
| us-gaap | SharePrice | Share Price | USD/shares | 1.85 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001171843-16-008207 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 4.5 | 2020-06-01 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | SharesPaidForTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares | 59,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001628280-24-007205 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 278.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -397.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 | |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan | Stock Issued During Period, Shares, Employee Stock Ownership Plan | shares | 193,000 | 2012-03-01 | 2012-03-15 | 2014 | FY | 10-K | 2015-03-02 | 0001171843-15-001186 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 369,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 3.85M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001628280-24-007205 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 1.28M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-27 | 0001628280-24-007205 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 251.66M | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 836,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForCash | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | USD | 25.00M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-08 | 0001193125-12-460637 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 49,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 0 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0001628280-25-007715 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 3.41M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | TangibleAssetImpairmentCharges | Tangible Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 410,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-27 | 0001628280-23-005259 | |
| us-gaap | TreasuryStockSharesAcquired | Treasury Stock, Shares, Acquired | shares | 12,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 |
| us-gaap | UndistributedEarningsOfForeignSubsidiaries | Undistributed Earnings of Foreign Subsidiaries | USD | 750,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-28 | 0001171843-22-001460 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 14.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 603,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 386,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 241,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-10 | 0001193125-14-091609 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | -68.22M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001628280-26-012240 |
| us-gaap | WeightedAverageNumberDilutedSharesOutstandingAdjustment | Weighted Average Number Diluted Shares Outstanding Adjustment | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 250.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 72.34M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-08 | 0001171843-15-002688 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 250.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001628280-26-070112 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) | shares | 47.10M | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-08 | 0001193125-12-218117 |